BRISTOL-MYERS SQUIBB CO (BRM.DE) Fundamental Analysis & Valuation

FRA:BRM • US1101221083

Current stock price

49.945 EUR
+0.27 (+0.53%)
Last:

This BRM.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BRM.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BRM was profitable.
  • In the past year BRM had a positive cash flow from operations.
  • Of the past 5 years BRM 4 years were profitable.
  • In the past 5 years BRM always reported a positive cash flow from operatings.
BRM.DE Yearly Net Income VS EBIT VS OCF VS FCFBRM.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • With a Return On Assets value of 7.83%, BRM perfoms like the industry average, outperforming 59.18% of the companies in the same industry.
  • With an excellent Return On Equity value of 38.19%, BRM belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
  • BRM has a better Return On Invested Capital (19.12%) than 77.55% of its industry peers.
  • BRM had an Average Return On Invested Capital over the past 3 years of 14.33%. This is in line with the industry average of 14.21%.
  • The last Return On Invested Capital (19.12%) for BRM is above the 3 year average (14.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.12%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.33%
ROIC(5y)12.84%
BRM.DE Yearly ROA, ROE, ROICBRM.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.64%, BRM is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
  • BRM's Profit Margin has improved in the last couple of years.
  • BRM's Operating Margin of 35.09% is amongst the best of the industry. BRM outperforms 87.76% of its industry peers.
  • In the last couple of years the Operating Margin of BRM has grown nicely.
  • Looking at the Gross Margin, with a value of 72.63%, BRM is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BRM has remained more or less at the same level.
Industry RankSector Rank
OM 35.09%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y12.45%
OM growth 5Y20.1%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
BRM.DE Yearly Profit, Operating, Gross MarginsBRM.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRM.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRM is creating value.
  • The number of shares outstanding for BRM has been increased compared to 1 year ago.
  • The number of shares outstanding for BRM has been reduced compared to 5 years ago.
  • The debt/assets ratio for BRM has been reduced compared to a year ago.
BRM.DE Yearly Shares OutstandingBRM.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BRM.DE Yearly Total Debt VS Total AssetsBRM.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • BRM has an Altman-Z score of 2.50. This is not the best score and indicates that BRM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BRM has a Altman-Z score of 2.50. This is comparable to the rest of the industry: BRM outperforms 46.94% of its industry peers.
  • The Debt to FCF ratio of BRM is 3.51, which is a good value as it means it would take BRM, 3.51 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BRM (3.51) is better than 63.27% of its industry peers.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that BRM has dependencies on debt financing.
  • BRM's Debt to Equity ratio of 2.33 is on the low side compared to the rest of the industry. BRM is outperformed by 79.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.5
ROIC/WACC2.15
WACC8.89%
BRM.DE Yearly LT Debt VS Equity VS FCFBRM.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • BRM has a Current Ratio of 1.26. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • BRM has a Current ratio (1.26) which is in line with its industry peers.
  • BRM has a Quick Ratio of 1.14. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BRM (1.14) is better than 69.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
BRM.DE Yearly Current Assets VS Current LiabilitesBRM.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BRM.DE Growth Analysis

3.1 Past

  • BRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
  • BRM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.92% yearly.
  • Looking at the last year, BRM shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
  • Measured over the past years, BRM shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, BRM will show a decrease in Earnings Per Share. The EPS will decrease by -4.46% on average per year.
  • Based on estimates for the next years, BRM will show a decrease in Revenue. The Revenue will decrease by -5.58% on average per year.
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.46%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.58%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRM.DE Yearly Revenue VS EstimatesBRM.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
BRM.DE Yearly EPS VS EstimatesBRM.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. BRM.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.55, the valuation of BRM can be described as very reasonable.
  • Based on the Price/Earnings ratio, BRM is valued cheaply inside the industry as 89.80% of the companies are valued more expensively.
  • BRM is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • BRM is valuated reasonably with a Price/Forward Earnings ratio of 9.27.
  • Based on the Price/Forward Earnings ratio, BRM is valued cheaper than 85.71% of the companies in the same industry.
  • BRM is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.55
Fwd PE 9.27
BRM.DE Price Earnings VS Forward Price EarningsBRM.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BRM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRM is cheaper than 83.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BRM is valued cheaper than 93.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.33
EV/EBITDA 7.31
BRM.DE Per share dataBRM.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BRM has a very decent profitability rating, which may justify a higher PE ratio.
  • BRM's earnings are expected to decrease with -4.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.23
PEG (5Y)N/A
EPS Next 2Y0.32%
EPS Next 3Y-4.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. BRM.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.27%, BRM is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.96, BRM pays a bit more dividend than its industry peers.
  • BRM's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.27%

5.2 History

  • On average, the dividend of BRM grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years4
Div Non Decr Years4
BRM.DE Yearly Dividends per shareBRM.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • BRM pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of BRM has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
BRM.DE Yearly Income VS Free CF VS DividendBRM.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
BRM.DE Dividend Payout.BRM.DE Dividend Payout, showing the Payout Ratio.BRM.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRM.DE Fundamentals: All Metrics, Ratios and Statistics

BRISTOL-MYERS SQUIBB CO

FRA:BRM (4/28/2026, 7:00:00 PM)

49.945

+0.27 (+0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength65.22
Industry Growth16.77
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap101.97B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target53.87 (7.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.27%
Yearly Dividend2.14
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)2.8%
PT rev (3m)10.5%
EPS NQ rev (1m)-1.81%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.3%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)3.29%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)6.9%
Valuation
Industry RankSector Rank
PE 9.55
Fwd PE 9.27
P/S 2.49
P/FCF 9.33
P/OCF 8.46
P/B 6.49
P/tB N/A
EV/EBITDA 7.31
EPS(TTM)5.23
EY10.47%
EPS(NY)5.39
Fwd EY10.79%
FCF(TTM)5.35
FCFY10.72%
OCF(TTM)5.9
OCFY11.82%
SpS20.09
BVpS7.7
TBVpS-9.33
PEG (NY)3.23
PEG (5Y)N/A
Graham Number30.103 (-39.73%)
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.39%
ROIC 19.12%
ROICexc 22.75%
ROICexgc 83.21%
OM 35.09%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.33%
ROIC(5y)12.84%
ROICexc(3y)17.09%
ROICexc(5y)15.28%
ROICexgc(3y)71.55%
ROICexgc(5y)85.11%
ROCE(3y)19.02%
ROCE(5y)17.03%
ROICexgc growth 3Y-4.44%
ROICexgc growth 5Y13.26%
ROICexc growth 3Y20.37%
ROICexc growth 5Y33.41%
OM growth 3Y12.45%
OM growth 5Y20.1%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.06
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.05
Cash Conversion 67.65%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.5
F-Score7
WACC8.89%
ROIC/WACC2.15
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.46%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.58%
EBIT growth 1Y46.5%
EBIT growth 3Y14.08%
EBIT growth 5Y23.15%
EBIT Next Year23.35%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.3%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / BRM.DE Fundamental Analysis FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 5 / 10 to BRM.DE.


What is the valuation status of BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (BRM.DE). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (BRM.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for BRM stock?

The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BRM.DE) is 9.55 and the Price/Book (PB) ratio is 6.49.


Can you provide the financial health for BRM stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (BRM.DE) is 5 / 10.